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The prooxidant-antioxidant balance in rats with oxidative stress was studied during
correction of the L-arginine-NO system. Oxidative stress was induced by intravenous
injection of E. coli lipopolysaccharide. Under conditions of oxidative stress the prooxi-
dant-antioxidant imbalance was least pronounced during selective correction of the
L-arginine-NO system. L-Arginine and nonselective NO synthase inhibitor had little pro-
tective effect.
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The formation of reactive oxygen metabolites (O2•–,
H2O2, OH radical, singlet oxygen, NO radical, and
peroxide radicals) plays a key role in the molecular
and cellular mechanisms of oxidative stress [1].
Free radical NO is synthesized in the organism and
provides various cell functions. However, NO in
high concentrations interacts with other oxidizers
forming reactive nitrogen species that can damage
target cells. Peroxynitrite formed from NO and O2
•
–
is a potent oxidizer reacting with biological mole-
cules. The complex relationship between reactive
nitrogen and oxygen species provides their syner-
gistic and antagonistic effects, which depends on
the rate of formation of NO and O2
•
–
 [4].
Here we studied the prooxidant-antioxidant ba-
lance under conditions of oxidative stress accom-
panied by correction of the L-arginine-NO system.
MATERIALS AND METHODS
Experiments were performed on 69 male labora-
tory rats weighing 190-230 g. The animals were
maintained in a vivarium at 20oC. Oxidative stress
was induced by intravenous injection of E. coli
lipopolysaccharide (LPS, Sigma) in a dose of 5 mg/kg
(common doses of LPS vary from 2 to 20 mg/kg
[8]), which led to the development of moderate
oxidative stress.
The L-arginine-NO system was corrected by
intravenous injection of L-arginine (300 mg/kg) 10
min before LPS administration. Nω-nitro-L-arginine
methyl ester (L-NAME, Sigma) was injected in a
dose of 20 mg/kg. A selective NO synthase inhi-
bitor L-lysine-Nω-acetamide (L-NIL, Sigma) in a dose
of 2 mg/kg was injected 45 min after LPS admini-
stration. Tissue samples were taken from the heart,
lungs, liver, kidneys, and muscles 180 min after
LPS administration. The doses and route of treatment
with the test preparations provided appreciable cor-
rection of NO synthesis in the organism [6,9].
The concentration of conjugated dienes (CD)
was estimated by measuring the amount of conju-
gated diene structures in hydroperoxides of poly-
unsaturated fatty acids [7]. The concentration of
Schiff bases was determined by fluorescence of a
chloroform extract at excitation and emission wave-
lengths of 344 and 440 nm, respectively. The mea-
surements were performed on an F-4010 spectro-
fluorometer (Hitachi) [7]. Catalase activity in bio-
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logical materials was evaluated by utilization of
H2O2, which forms a stable colored complex with
molybdenum salts, on a SF-46 spectrophotometer
at 410 nm [2]. α-Tocopherol was assayed by fluor-
escence of a heptane extract at excitation and emis-
sion wavelengths of 292 and 325 nm, respectively.
The measurements were performed on an F-4010
spectrofluorometer (Hitachi) [2].
The results were analyzed by Student’s t test.
RESULTS
Oxidative stress was accompanied by activation of
lipid peroxidation (LPO) in tissues (Figs. 1 and 2).
The concentration of CD in the heart, lungs, liver,
and kidneys increased by 137.6, 184.1, 101.2, and
90.4%, respectively. The concentration of Schiff
bases in the heart, lungs, liver, and kidneys increa-
sed by 99.2, 111.3, 81.8, and 121.3%, respectively
(p<0.001). Prooxidant-antioxidant imbalance in tis-
sues was least pronounced during selective correc-
tion of the L-arginine-NO system. Accumulation of
CD and Schiff bases was less significant under
these conditions. The concentration of CD in the
heart, lungs, liver, and kidneys increased by 27.6
(p<0.05), 32.6 (p<0.01), 27.4 (p<0.02), and 25.1%
(p<0.02), respectively. The concentration of Schiff
bases in the heart, lungs, liver, and kidneys increa-
sed by 13.8 (p<0.01), 26.1, 19.6, and 16.8% (p<0.001),
respectively. We studied the effect of LPS on the
main factors of the antioxidant defence system (Ta-
bles 1 and 2). Oxidative stress was accompanied
by a decrease in catalase activity and α-tocopherol
concentration in tissues. Catalase activity decreased
most significantly in the heart, lungs, liver and
kidneys (49.6, 51.7, 50.9, and 57.2%, respectively,
p<0.001). α-Tocopherol concentration decreased
most significantly in the lungs (54.9%). L-NIL ad-
ministration under conditions of oxidative stress
improved the antioxidant protection. L-Arginine
and nonselective NO synthase inhibitor L-NAME
produced no protective effect.
There are ambiguous data on the inhibition of
NO synthase. It is probably associated with dif-
ferences in the models of septic shock, doses of
NO synthesis inhibitors, stage of treatment with
corrective drugs, and local concentration of NO [5].
NO can produce a protective or depressive effect
depending on the severity of oxidative stress. Over-
production of radicals (relative to NO synthesis) is
accompanied by the induction of damage [3].
Our results show that NO modulates the de-
velopment of oxidative stress. High-specificity mar-
kers of oxidative stress (isoprostane concentration,
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degree of DNA damage, etc.) hold much promise
for evaluation of the role of NO in its pathogenesis.
This work was partially supported by the Bela-
russian Foundation for Basic Research.
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